Influence of angiotensin converting enzyme inhibitor treatment on cardiac autonomic modulation in patients receiving haemodialysis

Nephrology

Volumn 11, Issue 6, 2006, Pages 497-501

  Ondocin, Philip T ^a   Narsipur, Sriram S ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Angiotensin converting enzyme inhibitor; Cardiovascular disease; Dialysis; Heart rate variability; Uraemic autonomic neuropathy

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL;

ADD ON THERAPY; ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; AUTONOMIC NERVE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFECT; FEMALE; HEART ARRHYTHMIA; HEART FUNCTION; HEART HEMODYNAMICS; HEART RATE VARIABILITY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; KIDNEY FAILURE; MALE; MODULATION; PRIORITY JOURNAL; SECONDARY PREVENTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SUDDEN DEATH; SYMPATHETIC TONE; TREATMENT DURATION; TREATMENT OUTCOME; VAGUS TONE;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CASE-CONTROL STUDIES; DEATH, SUDDEN, CARDIAC; FEMALE; HEART; HEART RATE; HUMANS; HYPERTENSION, RENAL; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RAMIPRIL; RENAL DIALYSIS; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM; UREMIA; VAGUS NERVE;

EID: 33845631910     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00680.x     Document Type: Article

References (33)

1. USRDS. (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases). United States Renal Data System 1999 Annual Data Report. 1999 April.
2. Coronado B, Beck GJ, Greene T, Kusek JW, Levey AS. Cardiovascular disease risk factors and GFR in the MDRD study. JASN 1997; 8: 135A.
3. Foley RN, Parfrey PS, Harnett JD et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995; 47: 186-92.
4. Roithinger FX, Punzengruber C, Rossoll M, Pachinger O, Kramar R, Prischl FC. Ventricular late potentials in haemodialysis patients and the risk of sudden death. Nephrol. Dial. Transplant. 1992; 7: 1013-18.
5. Ramirez G, Brueggemeyer CD, Newton JL. Cardiac arrhythmias on hemodialysis in chronic renal failure patients. Nephron 1984; 36: 212-18.
6. Kimura K, Tabei K, Asano Y, Hosoda S. Cardiac arrhythmias in hemodialysis patients. A study of incidence and contributory factors. Nephron 1989; 53: 201-7.
7. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in hemodialysis patients. Kidney Int. 1999; 55: 1553-9.
8. Burgess ED. Cardiac vagal denervation in hemodialysis patients. Nephron 1982; 30: 228-30.
9. Kurata C, Uehara A, Sugi T et al. Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron 2000; 84: 312-19.
10. Thomson BJ, McAreavey D, Neilson JM, Winney RJ, Ewing DJ. Heart rate variability and cardiac arrhythmias in patients with chronic renal failure. Clin. Auton. Res. 1991; 1: 131-3.
11. Malik S, Winney RJ, Ewing DJ. Chronic renal failure and cardiovascular autonomic function. Nephron 1986; 43: 191-5.
12. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am. J. Cardiol. 1987; 59: 256-62.
13. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-65.
14. Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Schneider WJ, Stein PK. RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation 1995; 91: 1936-43.
15. Ponikowski P, Anker SD, Chua TP et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 1997; 79: 1645-50.
16. Pomeranz B, Macaulay R, Caudill M et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am. J. Physiol. 1985; 248: H151-3.
17. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 2000; 342: 145-53.
18. Minami J, Ishimitsu T, Kawano Y, Matsuoka H. Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients. Clin. Exp. Pharmacol. Physiol. 1998; 25: 572-6.
19. Steinberg AA, Mars RL, Goldman DS, Percy RF. Effect of end-stage renal disease on decreased heart rate variability. Am. J. Cardiol. 1998; 82: 1156-8, A10.
20. Krivitski NM, Depner TA. Cardiac output and central blood Volume during hemodialysis: Methodology. Adv. Ren. Replace. Ther. 1999; 6: 225-32.
21. Ewing DJ, Winney R. Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron 1975; 15: 424-9.
22. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG. Mechanisms of autonomic nervous system dysfunction in uraemia. Kidney Int. 1981; 20: 246-53.
23. Blankestijn PJ, Ligtenberg G, Klein IH, Koomans HA. Sympathetic overactivity in renal failure controlled by ACE inhibition: Clinical significance. Nephrol. Dial. Transplant. 2000; 15: 755-8.
24. Rump LC, Amann K, Orth S, Ritz E. Sympathetic overactivity in renal disease: A window to understand progression and cardiovascular complications of uraemia? Nephrol. Dial. Transplant. 2000; 15: 1735-8.
25. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N. Engl. J. Med. 1998; 339: 799-805.
26. Weinbergova O, Metelka R, Vymetal J, Konecny K, Kosatikova Z. Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 2004; 148: 69-73.
27. Bunag RD, Takahashi H. Exaggerated sympathetic responses to bradykinin in spontaneously hypertensive rats. Hypertension 1981; 3: 433-40.
28. Dominiak P, Elfrath A, Turck D. Effects of chronic treatment with ramipril, a new ACE blocking agent, on presynaptic sympathetic nervous system of SHR. Clin. Exp Hypertens. [A] 1987; 9: 369-73.
29. Ponchon P, Grichois ML, Girolami JP, Elghozi JL. Effects of bradykinin on short-term variability in blood pressure and heart rate in rats: A spectral study. J. Cardiovasc. Pharmacol. 1995; 25: 914-23.
30. Staszewska-Woolley J, Woolley G, Regoli D. Specific receptors for bradykinin-induced cardiac sympathetic chemoreflex in the dog. Eur. J. Pharmacol. 1988; 156: 309-14.
31. Tamura K, Tsuji H, Nishiue T, Yajima I, Higashi T, Iwasaka T. Determinants of heart rate variability in chronic hemodialysis patients. Am. J. Kidney Dis. 1998; 31: 602-6.
32. Rubinger D, Sapoznikov D, Pollak A, Popovtzer MM, Luria MH. Heart rate variability during chronic hemodialysis and after renal transplantation: Studies in patients without and with systemic amyloidosis. J. Am. Soc. Nephrol. 1999; 10: 1972-81.
33. Forsstrom J, Heinonen E, Valimaki I, Antila K. Effects of haemodialysis on heart rate variability in chronic renal failure. Scand. J. Clin. Lab. Invest. 1986; 46: 665-70.